Automate Your Wheel Strategy on MD
With Tiblio's Option Bot, you can configure your own wheel strategy including MD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MD
- Rev/Share 22.3446
- Book/Share 9.5995
- PB 1.6824
- Debt/Equity 0.7791
- CurrentRatio 1.7976
- ROIC 0.0713
- MktCap 1406409830.0
- FreeCF/Share 2.7157
- PFCF 5.9626
- PE 12.7613
- Debt/Assets 0.309
- DivYield 0
- ROE 0.1409
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Initiation | MD | Macquarie | -- | Outperform | -- | -- | Dec. 16, 2024 |
Upgrade | MD | Jefferies | Hold | Buy | $8 | $14 | Sept. 26, 2024 |
News
3 Medical Services Industry Stocks to Buy as AI Fuels Growth
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence adoption. COR, DOCS and MD are set to gain the most.
Read More
Wall Street Analysts Think Pediatrix Medical Group (MD) Could Surge 27.97%: Read This Before Placing a Bet
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 28% upside potential for Pediatrix Medical Group (MD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
Fast-paced Momentum Stock Pediatrix Medical Group (MD) Is Still Trading at a Bargain
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Read More
MD vs. HQY: Which Stock Should Value Investors Buy Now?
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Read More
Wall Street Analysts Believe Pediatrix Medical Group (MD) Could Rally 25.5%: Here's is How to Trade
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Pediatrix Medical Group (MD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
MD or HQY: Which Is the Better Value Stock Right Now?
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
Read More
MD Gains 11% Since Q4 Earnings Release, Unveils '25 View
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Pediatrix Medical's fourth-quarter results reflect a declining overall expense level. It estimates 2025 net income to lie within $98.3-$112.9 million.
Read More
Pediatrix Medical Group, Inc. (MD) Q4 2024 Earnings Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Pediatrix Medical Group, Inc. (NYSE:MD ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance & Strategy Mark Ordan - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants A.J. Rice - UBS Jack Levin - Jefferies Whit Mayo - Leerink Partners Benjamin Shaver - Deutsche Bank Operator Thank you for standing by.
Read More
Pediatrix Medical Gears Up for Q4 Results: What to Expect?
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive
MD's fourth-quarter results are likely to reflect declining revenues and expenses.
Read More
Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025
Published: February 10, 2025 by: Business Wire
Sentiment: Neutral
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025.
Read More
About Pediatrix Medical Group, Inc. (MD)
- IPO Date 1995-09-20
- Website https://www.mednax.com
- Industry Medical - Care Facilities
- CEO Mark S. Ordan
- Employees 4120